Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 76, Issue 1-5, 2001, Pages 119-124

  Rochefort, H ^a   Chalbos, D ^a   Cunat, S ^a   Lucas, A ^a   Platet, N ^a   Garcia, M ^a  

^a INSERM   (France)

Author keywords

Breast cancer; Cathepsin D; Estrogen

Indexed keywords

ANTIESTROGEN; CATHEPSIN D; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MASPIN; MATRIX METALLOPROTEINASE; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BINDING SITE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL LINE; CELL MOTILITY; CELL PROLIFERATION; CONFERENCE PAPER; HORMONAL REGULATION; HORMONE ACTION; HUMAN; MITOGENESIS; OVARY CANCER; PROTEIN EXPRESSION;

BREAST NEOPLASMS; ENDOPEPTIDASES; ESTROGENS; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROTEASE INHIBITORS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0034991631     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00142-4     Document Type: Article

References (50)

1. ECM and cell surface proteolysis: Regulating cellular ecology
2. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer
3. Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells
4. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
5. Cathepsin D in breast cancer: A tissue marker associated with metastasis
6. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: A meta-analysis
7. Cathepsin D in primary breast cancer: Prognostic evaluation involving 2810 patients
8. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency
9. Cathepsin D in breast cancer: Mechanisms and clinical applications a 1999 overview
10. Cathepsin D in cancer metastasis: A protease and a ligand
11. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors
12. The role of cathepsin D in the invasiveness of human breast cancer cells
13. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein
14. Mitogenic function of human procathepsin D: The role of the propeptide
15. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors
16. Activation of estrogen receptor transfected in a receptor negative breast cancer cell line decreases the metastatic and invasive potential of the cells
17. Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor
18. Estradiol stimulates cell growth and secretion of pro-cathepsin D and 120 kDa protein in the human ovarian cancer cell line BG-1
19. The regulation of growth and protein expression by estrogen in vitro: A study of 8 human ovarian carcinoma cell lines
20. Estradiol and fibulin-1 inhibit motility of human ovarian and breast cancer cells induced by fibronectin
21. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure
22. Estrogens increase the expression of fibulin-1, an extracellular matrix protein, secreted by human ovarian cancer cells
23. Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview
24. 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane
25. Association of increased basement membrane-invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
26. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms
27. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
28. A new bioassay using transient transfection for invasion-related gene analysis
29. Antiestrogen ICI 164384 reduces cellular estrogen receptor content by increasing its turnover
30. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-estrogen ICI 182780 in women with advanced breast cancer
31. Transcriptional control of matrixmetallo proteinases and the tissue inhibitors of matrix
32. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis
33. FRA-1 expression level modulates regulation of AP-1 activity by estradiol in breast cancer cells
34. Stromal cell expression of components of matrix-degrading protease systems in human cancer
35. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
36. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
37. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
38. D estradiol increases the production of 1-antichymotrypsin in MCF7 and T human breast cancer cell lines
39. Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer sublines
40. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells
41. Transactivation through ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin
42. Two types of plasminogen activators secreted by MCF-7 cells
43. Estradiol regulation of the components of the plasminogen-plasmin system in MDA-MB231 human breast cancer cells stably expressing the estrogen receptor
44. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
45. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
46. Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue
47. In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer
48. Release of estrogen-induced glycoprotein with a molecular weight of 52000 by breast cancer cells in primary culture
49. Changing views of the role of matrix metalloproteinases in metastasis